Medtronic Launches Solitaire X Revascularization Device in U.S.
Posted on May 01, 2019 by Medtech[y] Staff
Medtronic announced the U.S. launch of the Solitaire X Revascularization Device, which mechanically removes blood clots from blocked vessels in the brain to restore blood flow in patients suffering an acute ischemic stroke with large vessel occlusion.
The 4th generation device was also recently used for the first time in patients for the treatment of acute ischemic stroke.
Medtronic also introduced the Phenom 21 Catheter, a 160cm length microcatheter for the delivery of all sizes of Solitaire X. When combined with Phenom 21, the Solitaire X provides a low clot crossing profile and a smooth delivery to occlusions in distal vessels as small as 2.0mm.
"Medtronic continues to deliver technological innovations to advance stroke treatment. As a long-time Solitaire user, I am impressed with the ease of the Solitaire X delivery," said Dr. Reza Jahan, professor of radiology and neurosurgery at UCLA. "I find that Solitaire X 6x40 device combined with Phenom 21 catheter provides smooth navigation especially when working with complicated anatomy."
Are you a recruiter or company looking to fill a Medical Sales opening, including the medical device or biotech industries? If so, checkout Medtechy Jobs and create a free employer account or a free candidate account. All of our jobs are strategically distributed to our diverse following of experienced and those new to the industry. Multi-pack jobs start at $100.
We are also excited to launch Medtechy Deals, our new store which sources deals on gadgets, everyday carry essentials and online courses for employees in the healthcare industry!
Please follow us on Facebook, Twitter, and LinkedIn for the latest medical technology news, medical device/biotech company intel and career opportunities. You can also sign up for our monthly newsletter.